Dose Intensity for Oncology Clinical Trials

This paper introduces different methods of calculating RDI, and their associated nuances. It represents DI and RDI in a mock-up exposure analysis dataset, followed by recommendations on optimal data collection for analyzing dose intensity in clinical trials.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-08-15
DOI
https://doi.org/10.5281/zenodo.13324306
Primary Topic
Historical, Literary, and Cultural Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dose Intensity for Oncology Clinical Trials

Zenodo (CERN European Organization for Nuclear Research)
Historical, Literary, and Cultural Studies
article

Dose Intensity for Oncology Clinical Trials

article en

Abstract

This paper introduces different methods of calculating RDI, and their associated nuances. It represents DI and RDI in a mock-up exposure analysis dataset, followed by recommendations on optimal data collection for analyzing dose intensity in clinical trials.

Zenodo (CERN European Organization for Nuclear Research)
AbbVie (United States) (US)
Openalex Percentile: Top 33%
Historical, Literary, and Cultural Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Dose Intensity for Oncology Clinical Trials · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS